Xinxin Ding, PhD, department head, Pharmacology and Toxicology, College of Pharmacy—studies enzyme function, regulation and genetics as applied to translational research for drug safety and efficacy and genetic and environmental risks for chemical toxicity.
Author of nearly 200 peer-reviewed papers, book chapters and articles, he serves as associate editor for “Drug Metabolism and Disposition” and “Acta Pharmaceutica Sinica B.” Grants from the National Cancer Institute and National Institute of Environmental Health Sciences of the National Institutes of Health fund his work, in part. Former chair of the NIH XNDA study section (2016-2018), he chaired (2018-19) the Drug Metabolism and Disposition Division of the American Society for Pharmacology and Experimental Therapeutics.
PhD, Biological Chemistry, Medical School, University of Michigan, 1988
BS, Biology (Medical Physiology), Nanjing University (Nanjing, China), 1982
Genetic/environmental risks for chemical toxicity
American Society for Biochemistry and Molecular Biology, member (1988-Present)
International Society for the Study of Xenobiotics, Member (1993-Present)
Society of Toxicology, Member (1995-Present)
American Society for Pharmacology and Experimental Therapeutics, Member (1997-Present); Chair of Drug Metabolism and Disposition Division (2018-2019)
American Association for Cancer Research, member (2004-Present)